Study aims were addressed sequentially on independent cohorts of participants. (B) ESAT-6 free IGRA qualification plan. Blood was collected from healthy donors (n=12, Cohort 1b) directly in Quantiferon-TB Gold (QFT) tubes (Nil, TB Ag, Mitogen) and 8 ESAT-6 free IGRA (E6FI) tubes: 1 tube from lot 1; 3 tubes from lot 2; 4 tubes that had been stored at 4, 20, 37 and 50°C for 2 weeks prior to long term storage at 4°C. Upon incubation at 37°C for 16-20h, IFNg concentration was measured by QFT ELISA. Precision was assessed by comparing results obtained from 3 identical E6FI tubes (lot 2). Lot variability was assessed between results obtained from lot 1 and the average obtained from lot 2. Stability was assessed across results obtained from tubes stored at different temperatures, considering those stored at 4°C as reference. Concordance of qualitative results obtained from E6FI and QFT was also assessed.
: ESAT-6 free IGRA cut-off Blood was collected from M.tb-unexposed controls (n=50, black, Cohort 2a) and microbiologically-confirmed TB patients (n=51, purple, Cohort 2b) in Quantiferon-TB Gold (QFT) and ESAT-6 free IGRA (E6FI) tubes, stimulated for 16-20h at 37°C and IFNg concentration was measured by QFT ELISA (Figure 2 ). (A) E6FI sensitivity and specificity according to different cut-offs, calculated by ROC analysis, shown in Figure 2C . IFNg values measured by Quantiferon-TB Gold (QFT) and ESAT-6 free IGRA (E6FI) in adolescents (Cohort 3, described in Figure 3 and Table 1 ) with discordant results. The dotted lines denote assay cut-offs: 0.35 IU/mL for QFT (blue line) and 0.61 IU/mL for E6FI (red line). The yellow area denotes QFT uncertainty zone (0.2-0.7 IU/mL). Blood was collected from healthy donors (n=12, Cohort 1b) and analysed as described in Supplementary Figure 1B . ESAT-6 free IGRA (E6FI) tubes lot variation was assessed by (A) Bland-Altman analysis and (B) correlation between results obtained from lot #1 and lot #2 (data from Figure 4A ) (C) Precision of E6FI tubes was assessed by plotting mean IFNg values measured upon blood incubation in 3 E6FI tubes against their coefficient of variation (%CV) for each participant (data from Figure 4B Figure 1B and Figure 4 ) are plotted against the coefficient of variation (%CV) calculated between duplicate ELISA wells, to assess ELISA intra-assay variability (grey circles). Internal quality controls samples (n=3) were included in each ELISA plate (n=4) to assess ELISA inter-assay variability (red circles). E6FI tube stability was assessed by (D) Bland-Altman analysis and (E) correlation comparing results from E6FI tubes stored at the indicated temperatures to reference tubes stored at 4°C (data from Figure 4C ).
